CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool?

Autor: Yatomi-Clarke Steven L, Markovic Svetomir N, Quinn Michael A, Ashdown Martin L, Coventry Brendon J, Robinson Andrew P

Publikováno v: Journal of Translational Medicine, Vol 7, Iss 1, p 102 (2009)

Abstract The search for a suitable biomarker which indicates immune system responses in cancer patients has been long and arduous, but a widely known biomarker has emerged as a potential candidate for this purpose. C-Reactive Protein (CRP) is an acut

Externí odkaz: https://doaj.org/article/82b665d6e9614da89f2f9c87e2e09d8e

Chemotherapy for Late-Stage Cancer Patients: Meta-Analysis of Complete Response Rates.

Autor: Ashdown ML; Faculty of Medicine, University of Melbourne, Parkville, Victoria, Australia., Robinson AP; Department of Mathematics and Statistics, University of Melbourne, Parkville, Victoria, Australia., Yatomi-Clarke SL; Berbay Biosciences, Kew East, Victoria, Australia., Ashdown ML; ImmunAid Pty Ltd, Fitzroy, Victoria, Australia., Allison A; Centre for Biomedical Engineering (CBME), University of Adelaide, South Australia, Australia; School of Electrical & Electronic Engineering, University of Adelaide, South Australia, Australia., Abbott D; Centre for Biomedical Engineering (CBME), University of Adelaide, South Australia, Australia; School of Electrical & Electronic Engineering, University of Adelaide, South Australia, Australia., Markovic SN; Melanoma Study Group, Mayo Clinic Cancer Cente, Rochester, MN, USA., Coventry BJ; Department of Surgery & Tumour Immunology Laboratory, University of Adelaide, South Australia, Australia; Breast, Endocrine & Surgical Oncology Unit, Royal Adelaide Hospital, South Australia, Australia.

Publikováno v: F1000Research [F1000Res] 2015 Jul 13; Vol. 4, pp. 232. Date of Electronic Publication: 2015 Jul 13 (Print Publication: 2015).